Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1464046A Bacillus adhaerens and its use in preparing health food having thrombolysis property
12/31/2003CN1463972A Novel N-substituted pyridine Benzisoxazolone compound, method for making same and its pharmaceutical composition and use thereof
12/31/2003CN1463736A A pharmaceutical compound for treating coronary disease and stenocardia
12/31/2003CN1463733A Plaster for treating hypertension
12/31/2003CN1463729A Health care pillow containing traditional Chinese medicine
12/31/2003CN1463727A A TCM compound recipe notoginseng capsule and method for preparing the same
12/31/2003CN1463720A Ginseng-leech capsule for treating coronary disease and stenocardia and process for preparing same
12/31/2003CN1463718A A process of preparing medicine for treating cardiac cerebral arteriosclerosis
12/31/2003CN1463717A A process of preparing medicinal liquor for treating rheumatism and rheumatoid disease
12/31/2003CN1463716A Medicament compound for preventing and treating stroke sequelae
12/31/2003CN1463711A Radix salvia miltiorrhiza capsule compound and method for preparing same
12/31/2003CN1463706A Bingliushui traditional Chinese medicament
12/31/2003CN1463704A Novel usage of Aspirin-DL-Lysine
12/31/2003CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132621C Tibetans medicine for treating cardiac and cerebral vascular disease and white pulse disease
12/31/2003CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process
12/31/2003CN1132608C Chinese medicine for treating thromboangitis obliterans
12/31/2003CN1132607C Yunnan pine nut extract and preparation process and use thereof
12/31/2003CN1132606C Medicine for curing coronary heart disease with hypertension and its preparation process
12/31/2003CN1132596C Chinese medicine 'Zhidakang' for treating haemorrhoids and its preparing process
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CA2493865A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003CA2490526A1 Hetero-bicyclic compounds
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2489997A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003CA2489702A1 Novel anticholesterol compositions and method for using same
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670478 Process for preparing torsemide intermediate
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670382 Hydroxyformamidine derivatives and medicines containing the same
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670380 Pyridone inhibitors of fatty acid binding protein and method
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670362 Pyridazine endothelin antagonists
12/30/2003US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste
12/30/2003US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
12/30/2003US6669952 Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate
12/29/2003WO2004002469A1 Isoflavone concentrate and method for production thereof
12/29/2003CA2448513A1 Isoflavone concentrates, as well as methods for their production
12/25/2003WO2003105611A2 Beverages containing plant sterols
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236405 7-hetero-bicyclo[2.2.1]-heptanes
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236278 Serotonine receptors antagonist; central nervous system disorders
12/25/2003US20030236273 Aryl substituted pyrimidines and the use thereof
12/25/2003US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
12/25/2003US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
12/25/2003US20030236267 Benzimidazole derivatives
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236261 Potassium channel inhibitors
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236240 Macrocycles useful in the treatment of alzheimer's disease